Prevalence of fibromyalgia and associated factors in Spain


Por: Gaya, TF, Ferrer, CB, Mas, AJ, Seoane-Mato, D, Reyes, FA, Sanchez, MD, Dubois, CM, Sanchez-Fernandez, SA, Vargas, LMR, Morales, PVG, Olive, A, Munoz, PR, Larrosa, M, Ricos, NN, Sanchez-Piedra, C, Diaz-Gonzalez, F and Bustabad-Reyes, S

Publicada: 1 ene 2020
Resumen:
Objective. The prevalence of fibromyalgia (FM) differs depending on the population studied. The main objective of the EPISER2016 study was to estimate the prevalence of FM in adults in Spain. The secondary objective was to evaluate the association with sociodemographic and anthropometric characteristics and smoking. Methods. This is a population-based cross-sectional multicentre study. The random selection was based on multi-stage stratified cluster sampling. The final sample comprised 4916 persons aged >= 20 years. Participants were contacted by telephone for completion of a screening survey. Investigating rheumatologists evaluated positive results (review of medical records and/ or telephone interview, with medical visit if needed) to confirm the diagnosis. Prevalence and 95% confidence interval were calculated, taking into account the sample design. Weighing was applied based on age, sex, and geographic origin. Predictive models were constructed to analyse which sociodemographic, anthropometric and lifestyle variables in the call centre questionnaire were associated with the presence of FM. Results. 602 subjects (12 25%) had a positive screening result for FM, of which 24 were missing (3.99%). A total of 141 cases of FM were recorded. The estimated prevalence was 2.45% (95% CI, 2.06-2.90). Female sex was the variable most associated with FM, with an odds ratio (OR) of 10.156 (95% CI, 5.068-20352). Peak prevalence was at 60-69 years (p=0.009, OR=6.962). FM was 68% more frequent in obese individuals (OR, 1.689; 95% CI, 1.036-2.755). Conclusion. The prevalence of FM in adults in Spain barely changed between 2000 and 2016 and it is similar to that observed in Europe as a whole.

Filiaciones:
Gaya, TF:
 Hosp Comarcal Inca, Rheumatol, Baleares, Spain

Ferrer, CB:
 Hosp Comarcal Inca, Rheumatol, Baleares, Spain

Mas, AJ:
 Hosp Son Llatzer, Rheumatol, Cta Manacor Km 4, Palma De Mallorca 07198, Baleares, Spain

Seoane-Mato, D:
 Spanish Soc Rheumatol, Res Unit, Madrid, Spain

Reyes, FA:
 Hosp Univ Nuestra Senora de la Candelaria, Rheumatol, Santa Cruz De Tenerife, Spain

Sanchez, MD:
 Hosp Univ Nuestra Senora de la Candelaria, Rheumatol, Santa Cruz De Tenerife, Spain

Dubois, CM:
 Hosp Univ Marques de Valdecilla, Rheumatol, Santander, Spain

Sanchez-Fernandez, SA:
 Complejo Hosp Mancha Ctr, Rheumatol, Ciudad Real, Spain

Vargas, LMR:
 Complejo Hosp Mancha Ctr, Rheumatol, Ciudad Real, Spain

Morales, PVG:
 Complejo Hosp Mancha Ctr, Rheumatol, Ciudad Real, Spain

:
 Hosp Badalona Germans Trias & Pujol, Rheumatol, Barcelona, Spain

Munoz, PR:
 Hosp Badalona Germans Trias & Pujol, Rheumatol, Barcelona, Spain

Larrosa, M:
 Hosp Univ Parc Tauli, Rheumatol, Barcelona, Spain

Ricos, NN:
 Hosp Univ Parc Tauli, Rheumatol, Barcelona, Spain

Sanchez-Piedra, C:
 Spanish Soc Rheumatol, Res Unit, Madrid, Spain

Diaz-Gonzalez, F:
 Hosp Univ Canarias, Rheumatol, San Cristobal la Laguna, Santa Cruz De T, Spain

 Univ La Laguna, Dept Med Interna Dermatol & Psiquiatria, San Cristobal la Laguna, Santa Cruz De T, Spain

Bustabad-Reyes, S:
 Hosp Univ Canarias, Rheumatol, San Cristobal la Laguna, Santa Cruz De T, Spain
ISSN: 0392856X





Clinical and Experimental Rheumatology
Editorial
Pacini Editore SpA, VIA SANTA MARIA 31, 56126 PISA, ITALY, Italia
Tipo de documento: Article
Volumen: 38 Número: 1
Páginas: 47-52
WOS Id: 000521940500007

MÉTRICAS